Anemia in patients with tumors of the female reproductive system
https://doi.org/10.17650/1994-4098-2019-15-3-31-36
Abstract
Objective: to assess the efficacy of Sideral forte (combination of sucrosomial iron and vitamin C) in the treatment of iron deficiency anemia in patients with tumors of the female reproductive system.
Materials and methods. The study included 35 patients with benign tumors of the female reproductive system and 27 patients with cancer; all of them were also diagnosed with grade I iron deficiency anemia. The duration of therapy with Sideral forte at a dose of 1 capsule per day varied between 30 and 60 days. We evaluated frequency and intensity of clinical and hematological response to treatment, as well as drug tolerability.
Results. Therapy with Sideral forte ensured improvement of blood parameters in both patient groups. All participants received the drug during 8 weeks; it was well tolerated, demonstrated no side effects, and did not cause gastrointestinal disorders. The increase in the level of hemoglobin was observed in both groups; however, cancer patients had less pronounced dynamics.
Conclusions. Sideral forte is an effective oral drug that can be used for the treatment of iron deficiency anemia in patients with tumors of the female reproductive system.
About the Authors
A. G. Kedrova
Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency of Russia; Academy of Postgraduate Education under the Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency of Russia
Russian Federation
Competing Interests: not
Russian Federation
Department of Obstetrics and Gynecology APE.
28 Orekhovyy Boulevard, Moscow 115682; 91 Volokolamskoe Shosse, Moscow 125371
Competing Interests: not
T. A. Greyan
Academy of Postgraduate Education under the Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency of Russia
Russian Federation
Competing Interests: not
Russian Federation
Department of Obstetrics and Gynecology.
91 Volokolamskoe Shosse, Moscow 125371
Competing Interests: not
N. S. Vanke
Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency of Russia; Academy of Postgraduate Education under the Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency of Russia
Russian Federation
Competing Interests: not
Russian Federation
Department of Obstetrics and Gynecology APE.
28 Orekhovyy Boulevard, Moscow 115682; 91 Volokolamskoe Shosse, Moscow 125371
Competing Interests: not
S. E. Krasilnikovт
Novosibirsk Regional Clinical Narcology Dispensary
Russian Federation
Competing Interests: not
Russian Federation
21A Kainskaya St., Novosibirsk 630 007
Competing Interests: not
References
1. Ludwig H., Van B.S., Barrett-Lee P. et al. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer 2004;40:2293-306.
2. Chernov V.M., Ptushkin V.V. Anemia in cancer patients: current treatment options (literature review). Onkogematologiya = Hematologic Oncology 2013;8(2):77—82. DOI: 10.17650/1818-8346-2013-8-2-77-82. (In Russ.).
3. Ptushkin V.V. Anemia in oncology: treatment approaches. Sovremennaya onkologiya = Current Oncology 2012;14(1):58—63. (In Russ.).
4. UNICEF, United Nations University, WHO. Iron deficiency anemia: assessment, prevention and control. A guide for programme managers. Geneva: World Health Organization, 2001. P. 114.
5. Caro J.J., Salas M., Ward A., Goss G. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer 2001;91:2214-21. DOI: 10.1002/1097-0142(20010615)9:1:12<2214::aid-cncr1251>3.3.co;2-g.
6. Federal clinical guidelines for the diagnosis and treatment of iron deficiency anemia. Moscow: Standartinform, 2015. Available at: https://go-gl.com/moB (In Russ.).
7. Krause A., Neitz S., Magert H. et al. LEAP-1, a novel highly disulde-bonded human peptide, exhibits antimicrobial activity. FEBS Letters 2000;480:147-150.
8. Hillman R. Iron deficiency and other hyporegenerative anemias. Internal diseases by Tinsley R. Harrison. Trudniy patsient = Difficult Patient 2005;(2):770—9. (In Russ.).
9. Ganz T., Nemeth E. Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointest Liver Physiol 2006;290(2):199— 203. DOI: 10.1152/ajpgi.00412.2005.
10. Stuklov N.I., Basiladze I.G., Kovalchuk M.S. et al. New opportunities of treatment of iron deficiency syndromes in patients with inflammatory bowel diseases. Eksperimentalnaya i klinicheskaya gastroenterologiya = Experimental and Clinical Gastroenterology 2019;162(2):143— 50. (In Russ.).
11. Tarantino G. Ultrafer: liposomal iron in pregnancy increases birth weight. Abstract of the Vitafoods Europe Conference, 2014, Geneva.
12. Iron deficiency anemia, diagnosis. Treatment approaches, liposomal iron (Sideral Forte), treatment characteristics. Methodical guidline. Moscow, 2015. 24 p. (In Russ.).
13. Levakov S.A., Kedrova A.G., Vanke N.S. Anemia as a systemic manifestation in patients with proliferative disorders of the female reproductive system. Proceedings of the First Russian Research Conference “Clinical and Laboratory Aspects of Current Hematology”. Moscow, 2013. (In Russ.).
Review
For citations:
Kedrova A.G., Greyan T.A., Vanke N.S., Krasilnikovт S.E. Anemia in patients with tumors of the female reproductive system. Tumors of female reproductive system. 2019;15(3):31-36. (In Russ.) https://doi.org/10.17650/1994-4098-2019-15-3-31-36
Views:
1218
Email this article 